Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CLIA Medicare billing

This article was originally published in The Gray Sheet

Executive Summary

OIG recommends CMS prohibit labs from billing Medicare until they have paid all CLIA fees or been surveyed for compliance. Less than 1% of a 26,500-lab sample were paid by CMS for services not authorized by their waiver certificate in 1999, according to a January OIG report. The claims accounted for less than $76,000 of about $31.3 mil. paid for services submitted by waived labs. Based on the sample, OIG finds that CMS' Common Working File edits appear to be effective, resulting in denial of payment of 998 of 1,000 services...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016077

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel